

Based on the data provided, it appears that the company has a strong financial position with increasing revenue and profits. The operating cash flow is steady and expenses are well-controlled. There is no capital expenditure from bank payments or loan repayments, indicating good financial health. However, there is a large capital expenditure of US$150,000 in the second quarter which should be monitored closely to ensure that it does not have a negative impact on future cash flow. Overall, the company appears to be in good financial health with potential for further growth.